Join
Live feed
·
PRReleasevia Quantisnow
Abbott Laboratories logo

Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABT (Abbott Laboratories) and more on Quantisnow.